ライフサイエンスコーパス: choledocholithiasis

1 pproach based on preoperative probability of choledocholithiasis.

2 The major cause for obstructive jaundice was choledocholithiasis.

3 for patients presenting to the hospital with choledocholithiasis.

4 ulfill the criteria for a high likelihood of choledocholithiasis.

5 e clinical criteria for a high likelihood of choledocholithiasis.

6 reformations, for biliary duct narrowing and choledocholithiasis.

7 the detection of biliary duct narrowing and choledocholithiasis.

8 with balloon dilation for the management of choledocholithiasis.

9 fluid, and (e) common bile duct size and/or choledocholithiasis.

10 e, noninvasive modality for the detection of choledocholithiasis.

11 elical CT is useful for evaluating suspected choledocholithiasis.

12 hy-based treatment of patients with possible choledocholithiasis.

13 Of the patients who underwent ERCP for choledocholithiasis, 41.2% underwent early CCY, 10.9% un

14 inesia (65.3%), acute cholecystitis (26.6%), choledocholithiasis (5.7%), or gallstone pancreatitis (2

15 d into two groups based on the likelihood of choledocholithiasis according to the clinical predictors

16 there are an average of 26158 patients with choledocholithiasis admitted in the United States each y

17 The occurrence of choledocholithiasis among patients in the four groups we

18 tic imaging because of improved detection of choledocholithiasis and alternative causes of biliary ob

19 consequence of the endoscopic management of choledocholithiasis and the continuing controversy over

20 d therapy for malignant biliary obstruction, choledocholithiasis, and biliary complications post-live

21 r, in the evaluation of pancreatic cysts and choledocholithiasis, and in performing therapeutic proce

22 The management and diagnosis of choledocholithiasis are discussed, as well as endoscopic

23 modality for the diagnosis and resolution of choledocholithiasis before LC.

24 The probability of choledocholithiasis can be accurately assessed based on

25 Choledocholithiasis can be managed laparoscopically in e

26 o symptomatic cholelithiasis, cholecystitis, choledocholithiasis, cholangitis, or biliary pancreatiti

27 pecifically, the diagnosis and management of choledocholithiasis, complications of biliary endoscopy

28 The overall use of CBDE for patients with choledocholithiasis decreased from 39.8% of admissions i

29 enign biliary stricture, papillary stenosis, choledocholithiasis, extrinsic compression from pancreat

30 Stratification of risks for choledocholithiasis facilitates patient management with

31 r groups based on the level of suspicion for choledocholithiasis (group I, extremely high; group 2, h

32 thermore, an optimal management strategy for choledocholithiasis has yet to be defined.

33 nefits of LCBDE+LC over ERCP+LC for managing choledocholithiasis, if current trends continue, CBDE ma

34 Endoscopic management of choledocholithiasis in gallstone pancreatitis, a newer a

35 cholangiopancreatography (ERCP) by excluding choledocholithiasis in patients with acute pancreatitis

36 red with 264 controls with cholelithiasis or choledocholithiasis in the absence of cancer and with 12

37 cement positions, the timing and approach to choledocholithiasis in the context of anticipated cholec

38 evaluate secular trends in the management of choledocholithiasis in the United States and to compare

39 The choledocholithiasis management algorithm proposed by the

40 tricture (n = 12), choledochal cyst (n = 5), choledocholithiasis (n = 3), idiopathic cholangitis (n =

41 rategies for gallstone disease with possible choledocholithiasis: noncontrast MR cholangiopancreatogr

42 For detecting choledocholithiasis, observer 1 had a sensitivity of 77.

43 h sclerosing cholangitis, liver transplants, choledocholithiasis, or portosystemic shunts.

44 Diagnosis of choledocholithiasis requires clinical manifestations and

45 S: Cholecystectomy (CCY) after an episode of choledocholithiasis requiring endoscopic retrograde chol

46 s with an intermediate or high likelihood of choledocholithiasis requiring therapeutic ERCP.

47 85, and 0.98 for strictures, dilatation, and choledocholithiasis, respectively.

48 studied patients with a primary diagnosis of choledocholithiasis that were included in the National I

49 ospital length of stay between patients with choledocholithiasis treated with endoscopic retrograde c

50 (aged 18-94 years) with clinically suspected choledocholithiasis underwent unenhanced helical CT imme

51 tterns for performance of CCY after ERCP for choledocholithiasis using data from 3 large states and e

52 In 18 (19%) of 94 patients, choledocholithiasis was detected at reference examinatio

53 Choledocholithiasis was detected in 43 of 440 patients (

54 analysis of >4500 patients hospitalized with choledocholithiasis, we found that CCY was not performed

55 Patients with cholecysto-choledocholithiasis were randomized either to LERV or to

56 tation, and intraductal filling defects (all choledocholithiasis) were 86% (40 of 47) and 94% (45 of

57 ed data from 4516 patients hospitalized with choledocholithiasis who underwent ERCP.

58 Patients with suspected choledocholithiasis who underwent EUS between June 2009